Phase I/II evaluation of effervescent and enteric coated oral pamidronate for bone metastases
- 31 July 1991
- journal article
- other
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (7) , 945-946
- https://doi.org/10.1016/0277-5379(91)90158-a
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- COMPARISON OF THREE INTRAVENOUS BISPHOSPHONATES IN CANCER-ASSOCIATED HYPERCALCAEMIAThe Lancet, 1989
- REDUCED MORBIDITY FROM SKELETAL METASTASES IN BREAST CANCER PATIENTS DURING LONG-TERM BISPHOSPHONATE (APD) TREATMENTThe Lancet, 1987
- INHIBITION OF OSTEOLYTIC BONE LESIONS BY (3-AMINO-1-HYDROXYPROPYLIDENE)-1, 1-BISPHOSPHONATE (A.P.D.)The Lancet, 1979